Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 18, 2005

View Archived Issues

Antiinflammatory properties of drugs acting on the renin-angiotensin system

New data on the survival benefits of Provenge in advanced prostate cancer

Low-dose doxepin therapy shows promise in primary sleep maintenance insomnia

MAZ-51 directly inhibits tumor growth in preclinical models

Discovery of a novel family of antimicrobial peptides

Update on the safety and antiviral effects of Actilon in hepatitis C

Phase I study of ADMVA HIV vaccine opens enrollment

BAL-8557 enters phase II for esophageal candidiasis

Abgenix to receive milestone payment from Chiron for oncology antibody

BioLineRx inlicenses three new preclinical compounds

deCODE submits IND for novel antiatherosclerosis compound DG-041

Roche's AmpliChip CYP450 Test receives FDA clearance

Positive results from field efficacy study of FluINsure

Phase III study of ferumoxytol as intravenous iron replacement therapy

Phase IIa trials of PT-141 in FSD and ED complete enrollment

Series A financing at Chelsea Therapeutics

BAY-43-9006 studied for pancreatic cancer in NCI-sponsored phase II study

Good safety profile found for GR-270773 in septic patients

Clinical trial confirms the benefits of conivaptan in the management of hyponatremia

Phase II data on the efficacy of PHP in distributive shock

First clinical data on the efficacy of peginterferon alfa-2b monotherapy in chronic hepatitis B

New data on ethacrynic acid

Corgentech files IND to begin phase I/II trial of NF-kappaB Decoy in eczema

Combinations of modafinil and an antidepressant agent claimed by Cephalon

Pfizer claims PDE5 inhibitors for use in hypertension and diabetes

AstraZeneca scientists describe new agents for the treatment of pain

Researchers at ACRAF present novel analgesic compounds

Agents for the treatment of proliferative disorders described in patent literature

New therapeutic candidates for the treatment of Alzheimer's disease

Popular Stories

23andme founder-led group outbids Regeneron for company
BioWorld
The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...
Today's news in brief
BioWorld
BioWorld briefs for June 18, 2025.
Elevidys’ second liver death hits Sarepta, sends DMD ripples
BioWorld
How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 18, 2025.
EACR 2025: Immune rewiring in cancer orchestrates tumor microenvironment
BioWorld Science
Among the presentations included in the Top Abstracts category at the recently inaugurated Annual Congress of the European Association for Cancer Research (EACR)...